Quantexa is a London-headquartered decision-intelligence software company founded in 2016 by Vishal Marria. The company's platform builds entity-resolved knowledge graphs that help banks, government agencies, and large enterprises detect financial crime, manage risk, and enrich customer data.
Quantexa serves clients including HSBC, Standard Chartered, Vodafone, the UK Cabinet Office, and the US Internal Revenue Service. The principal UK entity, Quantexa Limited, is a private limited company registered at Companies House.
In April 2023, Quantexa closed a $129 million Series E led by GIC, Singapore's sovereign wealth fund, with participation from Warburg Pincus, Dawn Capital, Evolution Equity, AlbionVC, British Patient Capital, and HSBC, achieving a reported valuation of approximately $1.8 billion and confirming unicorn status.
The group has expanded into the US, the Middle East, Australia, and Asia-Pacific, with revenue growth driven by financial-crime regulatory pressure across G20 economies.
Quantexa is one of the most internationally regulated UK enterprise SaaS companies still operating as a private Ltd rather than as a listed plc, and its structure is widely studied as a blueprint for UK enterprise software businesses planning the path to a future LSE or US listing.
Quantexa is the most clearly IPO-track UK unicorn currently operating outside the consumer fintech segment, and its structure is a useful study in how a private English Ltd can scale to roughly $1.8 billion of equity value while remaining inside Companies House oversight.
The principal UK entity, Quantexa Limited, has raised seed, Series A, Series B, Series C, Series D, and Series E rounds, each filed as a fresh statement of capital introducing new preferred-share classes with associated liquidation preferences, anti-dilution ratchets, and protective provisions.
EIS-qualifying investors participated at the earliest stages, and EMI options have been used extensively to compensate engineering and commercial staff up to the GBP 30 million gross-asset threshold; later grants have shifted to unapproved options as the company exceeded EMI limits.
Quantexa's shareholder base now includes GIC, Warburg Pincus, Dawn Capital, Evolution Equity, AlbionVC, British Patient Capital (a UK government-backed fund managed by British Business Bank), and HSBC as a strategic investor.
The combination of British Patient Capital and HSBC is a textbook example of how the UK government's patient-capital framework, set up in response to the Patient Capital Review of 2017, channels institutional money into UK scale-ups alongside corporate strategics.
From a listing perspective, Quantexa would face the standard UK choice: LSE Main Market under the 2024 reformed regime now permits dual-class structures and lower free-float requirements, AIM is unlikely given the scale, and a US listing via Delaware inversion would access deeper enterprise-software multiples but at the cost of UK tax-residency restructuring.
Reverse-takeover routes are theoretically available but rarely used at this scale because the disclosure overhead is comparable to a full prospectus while access to capital is narrower.
Quantexa Limited is a private limited company incorporated in England and Wales and registered at Companies House, with its head office in Moorgate, London.
Yes. Quantexa achieved unicorn status in 2023 with a Series E led by GIC at a reported valuation of approximately $1.8 billion, making it one of the most highly valued UK enterprise SaaS companies.
Quantexa has not announced a listing. The 2024 LSE listing-regime reforms make a UK Main Market listing more viable than before, although a US listing via Delaware inversion remains a theoretical alternative.
Investors disclosed at Companies House include GIC, Warburg Pincus, Dawn Capital, Evolution Equity, AlbionVC, British Patient Capital, and HSBC as a strategic investor.
